Civic Intelligence

Lmsarcoma Direct Research Foundation

990 • Fiscal year 2021 • EIN 87-0763851

Jan 01, 2021 to Dec 31, 2021 • Filed on Nov 14, 2022

5927 South Louisville placeTulsa, OK 74135

(918) 637-6070

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

36th percentile

0.00x

Higher debt load relative to assets than 36% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Liabilities / Revenue

38th percentile

0.01x

Higher debt load relative to revenue than 38% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Net Margin

40th percentile

6.8%

Higher net margin than 40% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Top Officer Pay

52nd percentile

$0

Higher top officer pay than 52% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2021

Asset Growth

21st percentile

-3.0%

Faster asset growth than 21% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2020 to 2021

Revenue Growth

53rd percentile

16%

Faster revenue growth than 53% of similar nonprofits.

2021 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2020 to 2021

Assets

Down

$567,130

Down $17,763 (-3.0%) from 2020

Net Assets

Down

$565,298

Down $19,130 (-3.3%) from 2020

Liabilities

Up

$1,832

Up $1,367 (+294%) from 2020

Revenue

Up

$293,809

Up $41,381 (+16%) from 2020

Expenses

Down

$273,734

Down $11,519 (-4.0%) from 2020

Net Income

Up

$20,075

Up $52,900 (+161%) from 2020

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0Assets 2011: $143,921Liabilities 2011: $3912011Assets 2013: $188,626Liabilities 2013: $02013Assets 2014: $239,636Liabilities 2014: $02014Assets 2015: $280,057Liabilities 2015: $0Net Assets 2015: $280,0572015Assets 2016: $341,676Liabilities 2016: $0Net Assets 2016: $341,6762016Assets 2017: $565,100Liabilities 2017: $25Net Assets 2017: $565,0752017Assets 2018: $416,904Liabilities 2018: $0Net Assets 2018: $416,9042018Assets 2019: $617,253Liabilities 2019: $0Net Assets 2019: $617,2532019Assets 2020: $584,893Liabilities 2020: $465Net Assets 2020: $584,4282020Assets 2021: $567,130Liabilities 2021: $1,832Net Assets 2021: $565,2982021Assets 2022: $715,769Liabilities 2022: $1,832Net Assets 2022: $713,9372022Assets 2023: $915,978Liabilities 2023: $0Net Assets 2023: $915,9782023

Highlighted filing

2021

Assets$567,130
Liabilities$1,832
Net Assets$565,298

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2011: $47,690Expenses 2011: $32,680Net Income 2011: $15,0102011Revenue 2013: $53,852Expenses 2013: $8,756Net Income 2013: $45,0962013Revenue 2014: $198,170Expenses 2014: $131,278Net Income 2014: $66,8922014Revenue 2015: $163,710Expenses 2015: $123,289Net Income 2015: $40,4212015Revenue 2016: $320,050Expenses 2016: $258,431Net Income 2016: $61,6192016Revenue 2017: $230,378Expenses 2017: $6,979Net Income 2017: $223,3992017Revenue 2018: $142,257Expenses 2018: $290,428Net Income 2018: -$148,1712018Revenue 2019: $216,719Expenses 2019: $16,370Net Income 2019: $200,3492019Revenue 2020: $252,428Expenses 2020: $285,253Net Income 2020: -$32,8252020Revenue 2021: $293,809Expenses 2021: $273,734Net Income 2021: $20,0752021Revenue 2022: $374,295Expenses 2022: $225,656Net Income 2022: $148,6392022Revenue 2023: $432,152Expenses 2023: $230,111Net Income 2023: $202,0412023

Highlighted filing

2021

Revenue$293,809
Expenses$273,734
Net Income$20,075
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Nov 14, 2022
Return Version
2021v4.0
Gross Receipts
$293,809
Mission and Program Overview

Mission

To help find a cure for leiomyosarcoma by creating relationships with researchers and funding research that can lead to an effective treatment. To provide a forum for patients and care givers to share there experiences and to keep them informed of current studies.

To help find a cure for Leiomyosarcoma by creating a relationship with researchers in which we help fund projects that can lead to effective treatments. The secondary mission is to provide a forum for Patients and care givers to share information and access to the latest studies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$584,428$565,298▼ $19,130
Savings and Temporary Cash Investments$202,963$419,680▲ $216,717
Cash and Non-Interest-Bearing Accounts$381,930$147,450▼ $234,480
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$584,893$567,130▼ $17,763
Liabilities
Accounts Payable and Accrued Expenses$465$1,832▲ $1,367
Total Liabilities$465$1,832▲ $1,367
Net Assets / Fund Balance
Total Net Assets Fund Balance$584,428$565,298▼ $19,130
Total Liabilities and Net Assets / Fund Balance$584,893$567,130▼ $17,763
Compensation and Service Providers

Board Members and Trustees

NameTitle
Sharon AndersonPresident
Edward KurtzTreasurer and V. President
Howard SmithDirector
Denice BriceSecretary
Revenue and Support

Revenue Composition

Contributions and Grants
$288,641
Program Service Revenue
$0
Investment Income
$5,168
Other Revenue
$0
All Other Contributions
$288,641
Change in Net Assets
$20,075
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$262,518
Other Expenses$11,216
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$262,518--$262,518
Information Technology-$7,052-$7,052
Office Expenses-$2,239-$2,239
Other Expenses$0$1,576$0$1,576
Fees for Services Other-$199-$199
Fees for Services Accounting-$150-$150
Total Functional Expenses$262,518$11,216$0$273,734
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
McGill University--Metabolic Reprograming in Leiomyosarcoma and Gem/tax therapy resistance and response in Leiomyosarcoma.$150,000
Memorial Sloan KitteringNew York City, NY, CA501c3$100,000 awarded to Dr. Sujana Movva (Sloan Kettering) for her study, "Identifying Biomarkers Predictive of Benefit to Rucaparib and Nivolumab in Patients with Advanced Leiomyosarcoma." This study will analyze who responds the PARP inhibitor, Rucaparib. and $12518 for Identification of a Novel Treatment Strategy for Uterine Leiomyosarcoma in Genotype Defined Patient Population.$112,518
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

Edward Kurtz, Treasurer and Denice Brice, Secretary are Married.

Form 990, Part VI, Section A, Line 6

The Organization is an Oklahoma Not for Profit corporation. As such it has members.

Form 990, Part VI, Section A, Line 7A

The Corporation has Directors who elect officers.

Form 990, Part VI, Section B, Line 11B

After electronic filing, a pdf of the return is emailed to each officer and Director for approval and review.

Form 990, Part VI, Section B, Line 12C

There are very little opportunities for conflicts, expenses are very small and operations are simple and basic. Everything is very transparent through reviewing bank transactions.

Form 990, Part VI, Section C, Line 19

copies of governing documents are available upon request.

Filing and Contact Details

Filer

Filer Name
Lmsarcoma Direct Research Foundation
EIN
87-0763851
Phone
9186376070
Address
5927 South Louisville place, Tulsa, OK 74135
Doing Business As
Lmsdr

Signing Officer

Name
Edward Kurtz
Title
Treasurer
Phone
9186376070
Signed
2022-11-14

Organization Details

Principal Officer
Sharon Anderson
Formed
2006
Legal Domicile
Ok
Voting Board Members
4
Independent Board Members
3
Employees
0
Volunteers
8
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 2

$100.000 awarded to Dr. Joanna Przybyl (Stanford) for her 2-year project, "Metabolic Reprogramming in Leiomyosarcoma." This study will identify drugs that will block sources of energy in cancer cells of three genetic subgroups of LMS.

Raw XML Appendix390 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0465
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt01832
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0To help find a cure for Leiomyosarcoma by creating a relationship with researchers in which we help fund projects that can lead to effective treatments. The secondary mission is to provide a forum for Patients and care givers to share information and access to the latest studies.
IRS990/AllOtherContributionsAmt0288641
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/PersonNm0Ed Kurtz
IRS990/BooksInCareOfDetail/PhoneNum09186376070
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt05927 South Louisville place
IRS990/BooksInCareOfDetail/USAddress/CityNm0Tulsa
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0OK
IRS990/BooksInCareOfDetail/USAddress/ZIPCd074135
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0381930
IRS990/CashNonInterestBearingGrp/EOYAmt0147450
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0288641
IRS990/CYGrantsAndSimilarPaidAmt0262518
IRS990/CYInvestmentIncomeAmt05168
IRS990/CYOtherExpensesAmt011216
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt020075
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0273734
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0293809
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0$100,000 awarded to Dr. Sujana Movva (Sloan Kettering) for her study, "Identifying Biomarkers Predictive of Benefit to Rucaparib and Nivolumab in Patients with Advanced Leiomyosarcoma." This study will analyze who responds the PARP inhibitor, Rucaparib.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0LMSDR
IRS990/DoingBusinessAsName/BusinessNameLine2Txt0Leiomyosarcoma Support and Direct Research Foundation
IRS990/DonatedServicesAndUseFcltsAmt00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0112518
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FederatedCampaignsAmt00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0150
IRS990/FeesForServicesAccountingGrp/TotalAmt0150
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt0199
IRS990/FeesForServicesOtherGrp/TotalAmt0199
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt010
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/PersonNm0Sharon Anderson
IRS990/Form990PartVIISectionAGrp/PersonNm1Edward Kurtz
IRS990/Form990PartVIISectionAGrp/PersonNm2Howard Smith
IRS990/Form990PartVIISectionAGrp/PersonNm3Denice Brice
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/TitleTxt0President
IRS990/Form990PartVIISectionAGrp/TitleTxt1Treasurer and V. President
IRS990/Form990PartVIISectionAGrp/TitleTxt2Dir
IRS990/Form990PartVIISectionAGrp/TitleTxt3Secretary
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02006
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/FundraisingAmt00
IRS990/GainOrLossGrp/OtherAmt00
IRS990/GainOrLossGrp/SecuritiesAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GovernmentGrantsAmt00
IRS990/GrantAmt0112518
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0262518
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0262518
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0293809
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IncmFromInvestBondProceedsGrp/ExclusionAmt00
IRS990/IncmFromInvestBondProceedsGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IncmFromInvestBondProceedsGrp/UnrelatedBusinessRevenueAmt00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt07052
IRS990/InformationTechnologyGrp/TotalAmt07052
IRS990/InvestmentExpenseAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt00
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt05168
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt05168
IRS990/InvestmentIncomeGrp/UnrelatedBusinessRevenueAmt00
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0OK
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembershipDuesAmt00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0To help find a cure for leiomyosarcoma by creating relationships with researchers and funding research that can lead to an effective treatment. To provide a forum for patients and care givers to share there experiences and to keep them informed of current studies.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0584428
IRS990/NetAssetsOrFundBalancesEOYAmt0565298
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NoncashContributionsAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt02239
IRS990/OfficeExpensesGrp/TotalAmt02239
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0credit card fees
IRS990/OtherExpensesGrp/FundraisingAmt00
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt01576
IRS990/OtherExpensesGrp/ProgramServicesAmt00
IRS990/OtherExpensesGrp/TotalAmt01576
IRS990/OtherRevenueTotalAmt00
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0Sharon Anderson
IRS990/PriorPeriodAdjustmentsAmt0-39205
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0Mcgill University Grant Metabolic Reprogramming in Lieomyosarcoma Research and Gem Tax Therapy Resistance and Response
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0150000
IRS990/ProgSrvcAccomActy2Grp/GrantAmt0150000
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0247357
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0270000
IRS990/PYInvestmentIncomeAmt05071
IRS990/PYOtherExpensesAmt015253
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-32825
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0285253
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0252428
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt020075
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt00
IRS990/RentalIncomeOrLossGrp/PersonalAmt00
IRS990/RentalIncomeOrLossGrp/RealAmt00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990/RoyaltiesRevenueGrp/ExclusionAmt00
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/RoyaltiesRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt0584428
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt0565298
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0202963
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0419680
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0288641
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0247357
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0208426
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0139974
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0225679
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt01110077
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt05168
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt05071
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt0829
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt02284
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt04699
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt018051
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt05168
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt05071
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt0829
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt02284
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt04699
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt018051
IRS990ScheduleA/InvestmentIncomeCYPct00.01600
IRS990ScheduleA/InvestmentIncomePYPct00.021
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.98400
IRS990ScheduleA/PublicSupportPY509Pct00.979
IRS990ScheduleA/PublicSupportTotal509Amt01110077
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0288641
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0247357
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0208426
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0139974
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0225679
IRS990ScheduleA/Total509Grp/TotalAmt01110077
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0293809
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0252428
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0209255
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0142258
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0230378
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt01128128
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0112518
IRS990ScheduleI/RecipientTable/CashGrantAmt1150000
IRS990ScheduleI/RecipientTable/ForeignAddress/AddressLine1Txt0Glen Site 1001 Decarie Boulevard
IRS990ScheduleI/RecipientTable/ForeignAddress/CityNm0Montreal
IRS990ScheduleI/RecipientTable/ForeignAddress/CountryCd0CA
IRS990ScheduleI/RecipientTable/ForeignAddress/ForeignPostalCd0H4A 3j1
IRS990ScheduleI/RecipientTable/ForeignAddress/ProvinceOrStateNm0QC
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501c3
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0$100,000 awarded to Dr. Sujana Movva (Sloan Kettering) for her study, "Identifying Biomarkers Predictive of Benefit to Rucaparib and Nivolumab in Patients with Advanced Leiomyosarcoma." This study will analyze who responds the PARP inhibitor, Rucaparib. and $12518 for Identification of a Novel Treatment Strategy for Uterine Leiomyosarcoma in Genotype Defined Patient Population.
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1Metabolic Reprograming in Leiomyosarcoma and Gem/tax therapy resistance and response in Leiomyosarcoma.
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0Memorial Sloan Kittering
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1McGill University
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine2Txt0Cancer Research Program RI MUHC
IRS990ScheduleI/RecipientTable/RecipientEIN0131924236
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt0Box 27106
IRS990ScheduleI/RecipientTable/USAddress/CityNm0New York City
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0NY
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd0100877106
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0Proposals are received for Medical Research from the Researcher or their Organization and reviewed by a Medical Advisory group of Specialist. Grants are usually for one or two years. A report is usually issued on a 6 month to one year interval. Results are often reported in medical research magazines.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule I, Part I, Line 2
IRS990ScheduleI/Total501c3OrgCnt02
IRS990ScheduleI/TotalOtherOrgCnt00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0$100.000 awarded to Dr. Joanna Przybyl (Stanford) for her 2-year project, "Metabolic Reprogramming in Leiomyosarcoma." This study will identify drugs that will block sources of energy in cancer cells of three genetic subgroups of LMS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Edward Kurtz, Treasurer and Denice Brice, Secretary are Married.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2The Organization is an Oklahoma Not for Profit corporation. As such it has members.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3The Corporation has Directors who elect officers.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4After electronic filing, a pdf of the return is emailed to each officer and Director for approval and review.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5There are very little opportunities for conflicts, expenses are very small and operations are simple and basic. Everything is very transparent through reviewing bank transactions.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6copies of governing documents are available upon request.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part III, Line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section A, Line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section A, Line 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990, Part VI, Section A, Line 7a
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Form 990, Part VI, Section B, Line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Form 990, Part VI, Section B, Line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Form 990, Part VI, Section C, Line 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0584893
IRS990/TotalAssetsEOYAmt0567130
IRS990/TotalAssetsGrp/BOYAmt0584893
IRS990/TotalAssetsGrp/EOYAmt0567130
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0288641
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt011216
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0262518
IRS990/TotalFunctionalExpensesGrp/TotalAmt0273734
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0465
IRS990/TotalLiabilitiesEOYAmt01832
IRS990/TotalLiabilitiesGrp/BOYAmt0465
IRS990/TotalLiabilitiesGrp/EOYAmt01832
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0584428
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0565298
IRS990/TotalOtherCompensationAmt00
IRS990/TotalOtherProgSrvcExpenseAmt00
IRS990/TotalOtherProgSrvcGrantAmt00
IRS990/TotalOtherProgSrvcRevenueAmt00
IRS990/TotalProgramServiceExpensesAmt0262518
IRS990/TotalProgramServiceRevenueAmt00
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt05168
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0293809
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt08
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0584893
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0567130
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt0PO BOx 52697
IRS990/USAddress/CityNm0Tulsa
IRS990/USAddress/StateAbbreviationCd0OK
IRS990/USAddress/ZIPCd0741520697
IRS990/VotingMembersGoverningBodyCnt04
IRS990/VotingMembersIndependentCnt03
IRS990/WebsiteAddressTxt0https://lmsdr.org/
IRS990/WhistleblowerPolicyInd01
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL2
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/LastSubmissionRqrOOBCd01
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/OOBSecurityVerificationCd011
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd01
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Edward Kurtz
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Treasurer
ReturnHeader/BusinessOfficerGrp/PhoneNum09186376070
ReturnHeader/BusinessOfficerGrp/SignatureDt02022-11-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0LMSARCOMA DIRECT RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0LMSA
ReturnHeader/Filer/EIN0870763851
ReturnHeader/Filer/PhoneNum09186376070
ReturnHeader/Filer/USAddress/AddressLine1Txt05927 South Louisville place
ReturnHeader/Filer/USAddress/CityNm0Tulsa
ReturnHeader/Filer/USAddress/StateAbbreviationCd0OK
ReturnHeader/Filer/USAddress/ZIPCd074135
ReturnHeader/ReturnTs02022-11-14T17:56:45-07:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02021-01-01
ReturnHeader/TaxPeriodEndDt02021-12-31
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings